Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Tao Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2477-8004; OpenAlex author ID A5101567259. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism. Co-author DOI 10.3892/or.2017.5479↗
  2. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer. Last author DOI 10.1371/journal.pone.0097239↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Shan · 2 shared papers, 2014–2017 · strength 0.11
  2. Hong Long Ji · 2 shared papers, 2014–2017 · strength 0.11
  3. Wei Li · 1 shared paper, 2017 · strength 0.06
  4. Ya’an Kang · 1 shared paper, 2017 · strength 0.06
  5. Shuo Chen · 1 shared paper, 2017 · strength 0.06
  6. Hongwei Lü · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.